Molecular targets and biological modifiers in gastric cancer

被引：35
|
作者：
Carneiro, Fatima [1 ,2 ,3 ]
Oliveira, Carla [1 ,2 ]
Leite, Marina [1 ]
Seruca, Raquel [1 ,2 ]
机构：
[1] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal
[2] Univ Porto, Fac Med, P-4100 Oporto, Portugal
[3] Hosp Sao Joao, Dept Pathol, Oporto, Portugal
来源：
SEMINARS IN DIAGNOSTIC PATHOLOGY | 2008年 / 25卷 / 04期
关键词：
Gastric cancer; Molecular targets; Mutation; E-cadherin (CDHI); Microsatellite instability;
D O I：
10.1053/j.semdp.2008.07.004
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The overall survival of gastric cancer patients remains poor despite efforts and advances in its prevention, diaposis, and treatment. The development of new therapies is crucial for the effective control of this disease. An increasing number of genetic and epigenetic alterations have been associated with distinct histological types of gastric cancer. In this review, we will discuss the involvement of E-cadherin, EGFR, ERBB2, MMR genes, KRAS, and PIK3CA in the development and progression of gastric cancer and their role as biomarkers or as novel putative targets for therapy. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码：274 / 287
页数：14
相关论文
共 50 条
  • [31] BIOLOGICAL RESPONSE MODIFIERS - THEIR POTENTIAL AND LIMITATIONS IN CANCER THERAPEUTICS
    MIHICH, E
    CANCER INVESTIGATION, 1985, 3 (01) : 71 - 83
  • [32] BIOLOGICAL RESPONSE MODIFIERS - REALIZING THEIR POTENTIAL IN CANCER THERAPEUTICS
    TALMADGE, JE
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1986, 7 (07) : 277 - 281
  • [33] BIOLOGICAL RESPONSE MODIFIERS IN CANCER THERAPEUTICS - POTENTIALITIES AND LIMITATIONS
    MIHICH, E
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 531 - 535
  • [34] BIOLOGICAL RESPONSE MODIFIERS AS ADJUVANT TREATMENT IN GASTROINTESTINAL CANCER
    SEITZ, JF
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1994, 18 (8-9): : 726 - 732
  • [35] BIOLOGICAL RESPONSE MODIFIERS IN REGIONAL CANCER-THERAPY
    BERGH, JCS
    ACTA CHIRURGICA-THE EUROPEAN JOURNAL OF SURGERY, 1991, : 87 - 90
  • [36] BIOLOGICAL RESPONSE MODIFIERS PROGRAM AND CANCER-CHEMOTHERAPY
    OLDHAM, RK
    INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS, 1982, 4 (03): : 173 - 188
  • [37] Biological Clock Genes are Crucial and Promising Biomarkers for the Therapeutic Targets and Prognostic Assessment in Gastric Cancer
    Tian, Yonggang
    Xie, Yunqian
    Bai, Feihu
    Wang, Jun
    Zhang, Dekui
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (02) : 900 - 912
  • [38] Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer
    Bednarz-Misa, Iwona
    Fortuna, Paulina
    Diakowska, Dorota
    Jamrozik, Natalia
    Krzystek-Korpacka, Malgorzata
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 21
  • [39] Novel targets in gastric and esophageal cancer
    Valverde, Claudia Maria
    Macarulla, Teresa
    Casado, Esther
    Javier Ramos, Francisco
    Martinelli, Erika
    Tabernero, Josep
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (02) : 128 - 138
  • [40] Influence of histological (and molecular) classification on treatment choice and new therapeutic targets, in gastric cancer
    Stein, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 103 - 104
12345